Full text
PDF![866](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253a/1215234/f2af7cc001d0/brjopthal00287-0065.png)
![867](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253a/1215234/c4caaa88df24/brjopthal00287-0066.png)
![868](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253a/1215234/e9d857214326/brjopthal00287-0067.png)
![869](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253a/1215234/74dda4e76130/brjopthal00287-0068.png)
![870](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253a/1215234/912f764464a7/brjopthal00287-0069.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Watson P. G., Lobascher D. J., Sabiston D. W., Lewis-Faning E., Fowler P. D., Jones B. R. Double-blind trial of the treatment of episcleritis-scleritis with oxyphenbutazone or prednisolone. Br J Ophthalmol. 1966 Aug;50(8):463–481. doi: 10.1136/bjo.50.8.463. [DOI] [PMC free article] [PubMed] [Google Scholar]